In any given field of biomedical science like stem cell research and regenerative medicine, it’s very useful if you can accurately predict the future. It seems, though, that predictions are far more difficult within the more exciting and rapidly-changing fields. The field of stem cells and regenerative medicine fits that bill. Past stem cell research […]
21 Stem Cell Research & Regenerative Medicine 2021 Predictions Read More »
It’s encouraging to see that the states including now Arkansas via their attorney generals (or is it attorneys general?) are taking more action against stem cell clinic firms, but the big scope of AG action has somewhat surprised me. Arkansas AG suit The latest AG action on a stem cell clinic type firm comes from
Arkansas adds to wave of state AG actions vs. stem cell clinics Read More »
Are Trump and the Republican Party showing major hypocrisy over Trump’s use of experimental COVID-19 therapies in part developed by Regeneron using embryonic and fetal cells? The Internet is kind of blowing up over this. Trump’s collision with stem cells For example, people are directly confronting Trump on Twitter over his recent all caps tweet
Trump, GOP hypocrisy on Regeneron COVID-19 fetal, stem cell work Read More »
Should California’s Stem Cell Agency, more widely known as CIRM, get another round of funding from us California voters? I believe the answer is yes and I endorse Proposition 14, which would provide the funding for CIRM to translate dozens of clinical trials into some proven new stem cell-based treatments in the coming decade. However,
Seth Rogen is a stem cell pitching Prop 14 for CIRM in funny new video Read More »
The FDA and its CBER branch have been doing a good job overall in the last 3+ years to tackle the unproven stem cell clinic problem, but lately on the stem cells for COVID-19 front there is reason for real concern. I believe the agency is taking on major risk overall by clearing a vast number of
Politics & FDA OK of 2 stem cell clinic COVID-19 efforts Read More »
The term Regenerative Medicine covers so much biomedical science these days including everything from just about any kind of cell therapy (not just stem cells) to CRISPR gene editing, and with the the COVID-19 pandemic, it seems this umbrella use of the term now includes potential treatment of viral illnesses. It can be hard to
Update on stem cells for COVID-19, Surgisphere scandal Read More »
In what could be a serious legal warning sign for the stem cell field, California federal district court Judge Jesus Bernal denied the government’s motion for summary judgement against Cell Surgical Network, et al. related to their marketing of an unproven fat stem cell product via their chain of clinics. The FDA is seeking a
Last year around this time I took my annual plunge to make 20 predictions for the coming year for the stem cell and regenerative medicine field. I even made a crystal ball graphic to highlight the complexity of the stem cell ecosystem into which these predictions were embedded (see image) for 2019. How’d I do?
B+ on my report card on my 20 stem cell predictions for 2019 Read More »
The FDA just sent another untitled letter to a producer of a potentially non-compliant perinatal “stem cell” product that may be an unapproved drug. This follows past non-warning letters and/or inspection reports made public to Liveyon, R3 Stem Cell, Stemell, and others. RAPS has more on the story of the new letter here. This newest
Another FDA letter to a stem cell clinic supplier: what’s the agency’s long game? Read More »
Every so often I realize I’ve accumulated a bunch of tabs on my browsers of things I need to dive into as time permits, which sometimes translates into a collection of recommended reads here on The Niche. Here are some recommended recent reads in the stem cell/regenerative medicine field and childhood cancer space. It includes
Weekend reads: stem cells, CRISPR, glioma, stroke, RTT & more Read More »